Journals / Journal of Mood Disorders / 2015 / Cilt: 5 - Sayı: 1

MicroRNAs as a new hope for depression

Majör Depresyonun Tedavisinde ve Etyolojisinde Yeni Umutlar, Yeni Ufuklar: MikroRNA'lar

Pages
23–30
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For major depression, microRNAs are targetsfor both pharmacological and biological treatments, dis- regulated in animal models of depression and the brainsof depressed people, and are candidate biomarkers fordepression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Depression is a common and debilitating illness.
📊
Key Findings & Data:MicroRNAs are 22 nucleo- tides long and usually prevent protein synthesis frommRNAs at several stages.
💡
Conclusion & Impact:For major depression, microRNAs are targetsfor both pharmacological and biological treatments, dis- regulated in animal models of depression and the brainsof depressed people, and are candidate biomarkers fordepression.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Depression is a common and debilitating illness. Althougha great deal of research has been done in the area, itsneurobiology remains unclear. MicroRNAs are 22 nucleo- tides long and usually prevent protein synthesis frommRNAs at several stages. Now it is clear that microRNAsplay a key role in the pathophysiology of many diseases.They have the potential to regulate the expression of morethan 10,000 genes. Thus, microRNAs have been widelyinvestigated as they relate to both medical and psychiatricdisorders. For major depression, microRNAs are targetsfor both pharmacological and biological treatments, dis- regulated in animal models of depression and the brainsof depressed people, and are candidate biomarkers fordepression.

Özet

Depresyon oldukça sık görülen ve yeti yitimine nedenolan bir hastalıktır. Bu güne kadar yapılan birçok çalışmayarağmen halen nörobiyolojisi tam olarak aydınlatılabilmişdeğildir. MikroRNAlar yaklaşık 22 nükleotid uzunluğundaolup çoğunlukla mRNAlardan protein sentezini çeşitliaşamalarda engelleyerek işlev görürler. Daha öncede çöpRNAlar olarak bilinen bu yapılar şu an tam da bahsettiğimiz kritik noktada bulunmakta ve birçok hastalık için araştırmacıların ilgi noktası haline gelmektedir. Farmakolojikve biyolojik tedavilerin hedefi olduğunun gösterilmişolmasının yanı sıra gerek hayvan modelleri gerekse deperiferik kan ve post-mortem beyin çalışmaları mikroR- NAların depresyondaki önemini giderek perçinlemektedir.

🔖

Cite This Article

CAMKURT, M. A. (2022). MicroRNAs as a new hope for depression. Journal of Mood Disorders, Cilt: 5 - Sayı: 1, 23–30. https://ajindex.com/articles/564579

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Blazer DG, Kessler RC. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994;15:24-7
  2. Kendler KS, Karkowski LM, Prescott CA. Causal Relationship Between Stressful Life Events and the Onset of Major Depression. Am J Psychiatry. 1999;156:837-41
  3. Kendler KS, Karkowski-Shuman L. Stressful life events and genetic liability to major depression: genetic control of exposure to the environment? Psychol Med. 1997;27:539-47
  4. Andreasen NC. Linking Mind and Brain in the Study of Mental Illnesses: A Project for a Scientific Psychopathology. Science. 1997;275:1586-93
  5. Dolan RJ, Bench CJ, Liddle PF, Friston KJ, Frith CD, Grasby PM, Frackowiak RS. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity? J Neurol Neurosurg Psychiatry. 1993;56:1290-4
  6. McEwen BS. Effects of adverse experiences for brain structure and function. Biol Psychiatry. 2000;48:721-31
  7. Moreno FA, Rowe DC, Kaiser B, Chase D, Michaels T, Gelernter J, Delgado PL. Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry. 2002;7:213-6
  8. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature. 2002;416:396-400
  9. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97
  10. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415–9
  11. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005:123:631–40
  12. Ruby JG, Jan CH, Bartel DP. Intronic microRNA precursors that bypass Drosha processing. Nature. 2007;448:83–6
  13. Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, Liebhaber SA, et al. MicroRNA silencing through RISC recruitment of eIF6. Nature. 2007;447: 823–8
  14. Smalheiser NR, Lugli G. microRNA regulation of synaptic plasticity. Neuromolecular Med. 2009;11:133–40
  15. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Correction: Human MicroRNA Targets. PLoS Biol 3: Public Library of Sciencee 264
  16. Jin P, Zarnescu DC, Ceman S, Nakamoto M, Mowrey J, Jongens TA, et al. Biochemical and genetic interaction between the fragile X mental retardation protein and